New hope for myeloma patients with chromosome problems
NCT ID NCT00572169
First seen Feb 05, 2026 · Last updated May 10, 2026 · Updated 10 times
Summary
This study tests a new treatment plan for people newly diagnosed with multiple myeloma, a type of blood cancer. The goal is to see if adding a drug called bortezomib to a series of high-dose chemotherapy and stem cell transplants works better than previous treatments, especially for patients with certain chromosome abnormalities. About 177 participants will receive the therapy, which includes maintenance drugs to keep the cancer under control long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arkansas for Medical Sciences/Myeloma Institute
Little Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.